Liu et al. performed a retrospective case‐controlled prognostic assessment for different anti‐diabetic medications, including metformin, thiazolidinediones, sulfonylureas, meglitinides, acarbose as well as insulin and its analogues, in turn revealing that apart from pioglitazone and insulin, the other therapies failed to show an association with cancer incidence. Here, INS is linked to cancer.